Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Listeria monocytogenes | 3 | 2018 | 251 | 1.480 |
Why?
|
Listeriosis | 3 | 2018 | 150 | 1.160 |
Why?
|
Purpura, Hyperglobulinemic | 1 | 2020 | 2 | 0.730 |
Why?
|
Purpura | 1 | 2020 | 118 | 0.670 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 234 | 0.620 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 97 | 0.620 |
Why?
|
Bacteriolysis | 1 | 2016 | 51 | 0.530 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 599 | 0.510 |
Why?
|
Immunity, Cellular | 2 | 2016 | 1551 | 0.450 |
Why?
|
Cytosol | 1 | 2016 | 881 | 0.420 |
Why?
|
Immunity | 1 | 2018 | 993 | 0.400 |
Why?
|
Inflammasomes | 2 | 2016 | 519 | 0.400 |
Why?
|
Cell Death | 1 | 2016 | 1666 | 0.380 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2102 | 0.290 |
Why?
|
Hypopigmentation | 1 | 2023 | 44 | 0.220 |
Why?
|
Skin Pigmentation | 1 | 2023 | 269 | 0.200 |
Why?
|
Membrane Proteins | 1 | 2018 | 7788 | 0.190 |
Why?
|
Immunotherapy | 1 | 2016 | 4593 | 0.170 |
Why?
|
Preceptorship | 1 | 2019 | 57 | 0.160 |
Why?
|
Clinical Medicine | 1 | 2019 | 144 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2016 | 84 | 0.130 |
Why?
|
Thienamycins | 1 | 2015 | 27 | 0.130 |
Why?
|
Imipenem | 1 | 2015 | 36 | 0.130 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 317 | 0.130 |
Why?
|
Daptomycin | 1 | 2015 | 71 | 0.130 |
Why?
|
Dinoprostone | 1 | 2018 | 598 | 0.130 |
Why?
|
Penicillin-Binding Proteins | 1 | 2015 | 140 | 0.120 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2014 | 32 | 0.120 |
Why?
|
Acetaminophen | 1 | 2018 | 539 | 0.120 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2014 | 109 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2018 | 4516 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2016 | 309 | 0.110 |
Why?
|
Internal Medicine | 1 | 2019 | 1027 | 0.100 |
Why?
|
Milk | 1 | 2014 | 438 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2016 | 974 | 0.090 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21600 | 0.080 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 684 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2244 | 0.080 |
Why?
|
Monocytes | 1 | 2016 | 2545 | 0.070 |
Why?
|
Neoplasms | 1 | 2016 | 21716 | 0.070 |
Why?
|
Students, Medical | 1 | 2019 | 1878 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3025 | 0.070 |
Why?
|
Cosmetic Techniques | 1 | 2023 | 140 | 0.050 |
Why?
|
Mice | 3 | 2018 | 80264 | 0.050 |
Why?
|
Animals | 4 | 2018 | 166578 | 0.050 |
Why?
|
Models, Statistical | 1 | 2015 | 5037 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7215 | 0.040 |
Why?
|
Cefaclor | 1 | 2015 | 8 | 0.030 |
Why?
|
Cefotaxime | 1 | 2015 | 35 | 0.030 |
Why?
|
Nafcillin | 1 | 2015 | 24 | 0.030 |
Why?
|
Cefoxitin | 1 | 2015 | 34 | 0.030 |
Why?
|
Caspase 1 | 1 | 2016 | 226 | 0.030 |
Why?
|
Ceftriaxone | 1 | 2015 | 170 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 78360 | 0.030 |
Why?
|
Mentors | 1 | 2019 | 651 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23155 | 0.030 |
Why?
|
Career Choice | 1 | 2019 | 743 | 0.030 |
Why?
|
Child | 1 | 2020 | 78520 | 0.020 |
Why?
|
Female | 4 | 2019 | 382565 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1734 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1690 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 2014 | 967 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2456 | 0.020 |
Why?
|
Cytokines | 2 | 2016 | 7239 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 1983 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4390 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2015 | 1113 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1868 | 0.020 |
Why?
|
Humans | 5 | 2023 | 746839 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2196 | 0.020 |
Why?
|
Environment | 1 | 2014 | 1115 | 0.020 |
Why?
|
NF-kappa B | 1 | 2016 | 2465 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3686 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6228 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6463 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5762 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3741 | 0.010 |
Why?
|
Male | 2 | 2019 | 351538 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7576 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 57215 | 0.010 |
Why?
|
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_